DE3805523A1 - Pharmazeutische praeparate zur transdermalen applikation von heparin - Google Patents
Pharmazeutische praeparate zur transdermalen applikation von heparinInfo
- Publication number
- DE3805523A1 DE3805523A1 DE3805523A DE3805523A DE3805523A1 DE 3805523 A1 DE3805523 A1 DE 3805523A1 DE 3805523 A DE3805523 A DE 3805523A DE 3805523 A DE3805523 A DE 3805523A DE 3805523 A1 DE3805523 A1 DE 3805523A1
- Authority
- DE
- Germany
- Prior art keywords
- heparin
- fatty acid
- choline
- pharmaceutical preparations
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 229960002897 heparin Drugs 0.000 title claims abstract description 20
- 229920000669 heparin Polymers 0.000 title claims abstract description 20
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 12
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 10
- 229930195729 fatty acid Natural products 0.000 claims abstract description 10
- 239000000194 fatty acid Substances 0.000 claims abstract description 10
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 9
- 229960001231 choline Drugs 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000003883 ointment base Substances 0.000 claims abstract description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 239000002674 ointment Substances 0.000 claims description 6
- 239000004381 Choline salt Substances 0.000 claims description 4
- 235000019417 choline salt Nutrition 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 150000003248 quinolines Chemical class 0.000 claims description 4
- -1 Choline fatty acid salt Chemical class 0.000 claims description 3
- SGFBLYBOTWZDDE-UHFFFAOYSA-N Choline stearate Chemical group CCCCCCCCCCCCCCCCCC(=O)OCC[N+](C)(C)C SGFBLYBOTWZDDE-UHFFFAOYSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 229960001849 choline stearate Drugs 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 1
- 239000012050 conventional carrier Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract description 3
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 description 5
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3805523A DE3805523A1 (de) | 1988-02-22 | 1988-02-22 | Pharmazeutische praeparate zur transdermalen applikation von heparin |
| ES89102823T ES2040391T3 (es) | 1988-02-22 | 1989-02-18 | Procedimiento para producir composiciones farmaceuticas para la aplicacion transdermica de heparina. |
| AT89102823T ATE71529T1 (de) | 1988-02-22 | 1989-02-18 | Pharmazeutische praeparate zur transdermalen applikation von heparin. |
| EP89102823A EP0331948B1 (en) | 1988-02-22 | 1989-02-18 | Pharmaceutical composition for the transdermal administration of heparin |
| DE8989102823T DE68900693D1 (de) | 1988-02-22 | 1989-02-18 | Pharmazeutische praeparate zur transdermalen applikation von heparin. |
| IE53789A IE61287B1 (en) | 1988-02-22 | 1989-02-20 | Pharmaceutical composition for the transdermal application of herparin |
| DK079289A DK79289A (da) | 1988-02-22 | 1989-02-21 | Farmaceutisk praeparat til transdermal applikation af heparin |
| PT89781A PT89781B (pt) | 1988-02-22 | 1989-02-22 | Processo para a preparacao de composicoes farmaceuticas de aplicacao intradermica de heparina |
| GR920400096T GR3003666T3 (enExample) | 1988-02-22 | 1992-01-29 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3805523A DE3805523A1 (de) | 1988-02-22 | 1988-02-22 | Pharmazeutische praeparate zur transdermalen applikation von heparin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3805523A1 true DE3805523A1 (de) | 1989-10-05 |
Family
ID=6347919
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE3805523A Withdrawn DE3805523A1 (de) | 1988-02-22 | 1988-02-22 | Pharmazeutische praeparate zur transdermalen applikation von heparin |
| DE8989102823T Expired - Fee Related DE68900693D1 (de) | 1988-02-22 | 1989-02-18 | Pharmazeutische praeparate zur transdermalen applikation von heparin. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8989102823T Expired - Fee Related DE68900693D1 (de) | 1988-02-22 | 1989-02-18 | Pharmazeutische praeparate zur transdermalen applikation von heparin. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0331948B1 (enExample) |
| AT (1) | ATE71529T1 (enExample) |
| DE (2) | DE3805523A1 (enExample) |
| DK (1) | DK79289A (enExample) |
| ES (1) | ES2040391T3 (enExample) |
| GR (1) | GR3003666T3 (enExample) |
| IE (1) | IE61287B1 (enExample) |
| PT (1) | PT89781B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302135D0 (sv) * | 1993-06-18 | 1993-06-18 | Kabi Pharmacia Ab | New pharmaceutical composition |
| RU2107492C1 (ru) * | 1997-01-22 | 1998-03-27 | Открытое акционерное общество "Нижегородский химико-фармацевтический завод" | Мазь для лечения тромбофлебита |
| ITMI20042505A1 (it) * | 2004-12-24 | 2005-03-24 | Oro Consulting S R L | Sostanza emulsionante e-o tensioattiva ad attivita' battericida per la preparazione di emulsioni e di tensidi per uso dermofarmaceutico e cosmetico emulsioni e tensidi preparati con questa sostanzaa prodotto dermofarmaceutico e prodotto cosmetico ott |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4729989A (en) * | 1985-06-28 | 1988-03-08 | Merck & Co., Inc. | Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts |
| US4692441A (en) * | 1985-08-16 | 1987-09-08 | Merck & Co., Inc. | Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities |
-
1988
- 1988-02-22 DE DE3805523A patent/DE3805523A1/de not_active Withdrawn
-
1989
- 1989-02-18 DE DE8989102823T patent/DE68900693D1/de not_active Expired - Fee Related
- 1989-02-18 AT AT89102823T patent/ATE71529T1/de not_active IP Right Cessation
- 1989-02-18 EP EP89102823A patent/EP0331948B1/en not_active Expired - Lifetime
- 1989-02-18 ES ES89102823T patent/ES2040391T3/es not_active Expired - Lifetime
- 1989-02-20 IE IE53789A patent/IE61287B1/en not_active IP Right Cessation
- 1989-02-21 DK DK079289A patent/DK79289A/da not_active Application Discontinuation
- 1989-02-22 PT PT89781A patent/PT89781B/pt not_active IP Right Cessation
-
1992
- 1992-01-29 GR GR920400096T patent/GR3003666T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2040391T3 (es) | 1996-07-16 |
| DK79289A (da) | 1989-08-23 |
| DE68900693D1 (de) | 1992-02-27 |
| EP0331948B1 (en) | 1992-01-15 |
| ATE71529T1 (de) | 1992-02-15 |
| IE890537L (en) | 1989-08-22 |
| DK79289D0 (da) | 1989-02-21 |
| GR3003666T3 (enExample) | 1993-03-16 |
| PT89781B (pt) | 1994-05-31 |
| IE61287B1 (en) | 1994-10-19 |
| PT89781A (pt) | 1989-10-04 |
| EP0331948A2 (en) | 1989-09-13 |
| EP0331948A3 (en) | 1990-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69017654T2 (de) | Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung. | |
| DE69425904T2 (de) | Hautbräunungsmittel | |
| DE2207294C2 (de) | Topische Salbengrundlage | |
| DE3382616T2 (de) | Vermittler des durchdringungsvermoegens zur transdermalen verabreichung systemischer wirkstoffe. | |
| DE69415491T2 (de) | Wasser in Öl Emulsion enthaltend Retinol | |
| DE3751761T2 (de) | Penetrationsverbesserer für die transdermale Verabreichung von systemisch wirksamen Arzneimitteln | |
| DE69419375T2 (de) | Wasserfreies kosmetisches oder pharmazeutisches Mittel enthaltend Retinol | |
| DE69526882T2 (de) | Esculosid enthaltende Zubereitungen und ihre Verwendung in der Kosmetik und Pharmazie | |
| DE2818553A1 (de) | Zusammensetzung zur behandlung von proliferativen hautkrankheiten | |
| DE3836971C1 (enExample) | ||
| DE2947742C2 (de) | Arzneimittel, enthaltend β-Cyclodextrin | |
| DE2610020A1 (de) | Pharmazeutische zusammensetzung | |
| EP0705102A1 (de) | Verwendung von corrinoiden zur topischen anwendung bei hauterkrankungen | |
| DE2840498C2 (de) | Pharmazeutische Zubereitungen zur Behandlung von Psoriasis | |
| DE68906513T2 (de) | Topisch anzuwendende diclofenac enthaltende arzneizubereitungen. | |
| AT403434B (de) | Topische zusammensetzung zur beschleunigung der wundheilung | |
| DE69000960T2 (de) | Zusammensetzung zur behandlung von pigmentierung. | |
| ATE1442T1 (de) | Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung. | |
| EP0331948B1 (en) | Pharmaceutical composition for the transdermal administration of heparin | |
| DE69109815T2 (de) | Lactulose enthaltende wasserfreie Zusammensetzung. | |
| DE69624992T2 (de) | Pharmazeutische Zusammensetzungen zum topischen Gebrauch enthaltend Ketoprofen | |
| CH688760A5 (de) | Topisches Praeparat zur Foerderung des Muskelaufbaus. | |
| DE3780702T2 (de) | Verwendung von etodolac zur senkung des blutgehalts an harnsaeure. | |
| DE2745943C2 (enExample) | ||
| DE648606C (de) | Verfahren zur Herstellung einer Salbengrundlage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |